Table S5. Effects of clinical characteristics on baseline LCBI (n=74).

Parameter	Baseline LCBI		P value
	Yes/+	No/−
Female	14 [0, 103]	56 [25, 114]	0.04
Current smoker	58 [25, 97]	43 [5, 114]	0.59
ACS	74 [32, 145]	39 [4, 85]	0.07
Diabetes	66 [13, 161]	42 [16, 94]	0.61
Hypertension	42 [16, 112]	57 [2, 94]	0.94
Dyslipidemia	42 [20, 109]	58 [1, 118]	0.82
Medication
Aspirin	49 [16, 114]	23 [0, 94]	0.22
ACE-I/ARB	39 [16, 97]	48 [11, 118]	0.87
Statin	55 [20, 118]	43 [1, 72]	0.28
HIST	41 [16, 118]	47 [7, 94]	0.99
Beta-blocker	46 [24, 112]	45 [5, 97]	0.61

Values are median [interquartile range]. ACS, acute coronary syndrome; ACE-I, angiotensin converting enzyme inhibitor; ARB, angiotensin II receptor; HIST, high-intensity statin therapy; LCBII, lipid core burden index.